Chihiro Sato

Affiliations: 
Washington University School of Medicine, St. Louis, MO, United States 
Area:
Neuroscience
Google:
"Chihiro Sato"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Horie K, Salvadó G, Barthélemy NR, et al. (2023) CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature Medicine
Sun Z, Kwon JS, Ren Y, et al. (2023) Endogenous recapitulation of Alzheimer's disease neuropathology through human 3D direct neuronal reprogramming. Biorxiv : the Preprint Server For Biology
Barthélemy NR, Saef B, Li Y, et al. (2023) CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. Nature Aging. 3: 391-401
Horie K, Li Y, Barthélemy NR, et al. (2023) Change in cerebrospinal fluid tau microtubule binding region detects symptom onset, cognitive decline, tangles, and atrophy in Dominantly Inherited Alzheimer's Disease. Annals of Neurology
Mahali S, Martinez R, King M, et al. (2022) Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration. Translational Psychiatry. 12: 508
Horie K, Barthélemy NR, Spina S, et al. (2022) CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nature Medicine
Capano LS, Sato C, Ficulle E, et al. (2022) Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. Cell Stem Cell. 29: 918-932.e8
Lim YY, Maruff P, Barthélemy NR, et al. (2022) Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. Jama Neurology
Ezerskiy LA, Schoch KM, Sato C, et al. (2021) Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction. Jci Insight
Sato C, Mallipeddi N, Ghoshal N, et al. (2021) MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology. Annals of Clinical and Translational Neurology
See more...